ANI Pharmaceuticals, Inc. (ANIP)

ANI Pharmaceuticals Stock Forecast

Stock Price Forecast

The 6 analysts that cover ANI Pharmaceuticals stock have a consensus rating of "Strong Buy" and an average price target of $105.83, which forecasts a 24.08% increase in the stock price over the next year. The lowest target is $90 and the highest is $121.

Price Target: $105.83 (+24.08%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$90	$105.83	$115	$121
Change	+5.52%	+24.08%	+34.83%	+41.87%

* Price targets were last updated on Dec 9, 2025.

Analyst Ratings

The average analyst rating for ANI Pharmaceuticals stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Aug '25	Sep '25	Oct '25	Nov '25	Dec '25	Jan '26
Strong Buy	4	4	4	4	3	3
Buy	4	3	3	2	3	2
Hold	1	1	1	1	1	1
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	9	8	8	7	7	6

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Glen Santangelo Barclays	Barclays	Buy Initiates $100	Buy	Initiates	$100	+17.25%	Dec 9, 2025
Vamil Divan Guggenheim	Guggenheim	Strong Buy Maintains $114 → $115	Strong Buy	Maintains	$114 → $115	+34.83%	Nov 10, 2025
Gregory Fraser Truist Securities	Truist Securities	Hold Maintains $77 → $90	Hold	Maintains	$77 → $90	+5.52%	Oct 9, 2025
Ekaterina Knyazkova JP Morgan	JP Morgan	Buy Maintains $95 → $115	Buy	Maintains	$95 → $115	+34.83%	Sep 24, 2025
Brandon Folkes HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Maintains $93 → $121	Strong Buy	Maintains	$93 → $121	+41.87%	Sep 17, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

886.97M

Increased by 44.37%

from 614.38M

Revenue Next Year

974.15M

Increased by 9.83%

from 886.97M

EPS This Year

7.65

from -1.04

EPS Next Year

8.56

Increased by 11.83%

from 7.65

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	208.48M	216.14M	316.39M	486.82M	614.38M	886.97M	974.15M
Revenue Growth	0.93%	3.68%	46.38%	53.87%	26.20%	44.37%	9.83%
EPS	-1.88	-3.40	-3.05	0.85	-1.04	7.65	8.56
EPS Growth	-	-	-	-	-	-	11.83%
Forward PE	-	-	-	-	-	11.14	9.97
No. Analysts	-	-	-	-	-	10	10

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027	2028	2029	2030
High	922.4M	1.1B
Avg	887.0M	974.2M
Low	848.7M	894.7M

Revenue Growth

Revenue Growth	2025	2026	2027	2028	2029	2030
High	50.1%	19.2%
Avg	44.4%	9.8%
Low	38.1%	0.9%

EPS Forecast

EPS	2025	2026	2027	2028	2029	2030
High	8.03	10.21
Avg	7.65	8.56
Low	7.02	7.38

EPS Growth

EPS Growth	2025	2026	2027	2028	2029	2030
High	-	33.4%
Avg	-	11.8%
Low	-	-3.6%

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.